First AD

Second AD

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

EU Perspective: Evolving Topics in Prostate Cancer 

Peer Exchange

M0 Stage Prostate Cancer

Radiotherapy for Oligometastatic Prostate Cancer

Defining Disease Volume in Metastatic Prostate Cancer

Nonmetastatic CRPC: Does It Exist?

Biochemical Prostate Cancer Recurrence Post Surgery/RT

Bone Health in Prostate Cancer

Key Updates: Bone-Targeted Therapy for Metastatic CRPC

Effect of Prostate Cancer Therapies on Bone Metabolism

ERA 223 and Implications for Clinical Practice

Assessment of Bone Health in Prostate Cancer

Earlier Detection of Prostate Cancer Bone Metastases

Therapeutic Sequencing for CRPC Based on Recent Data

Genotyping in Prostate Cancer

PARP Inhibitors in Advanced Prostate Cancers

Chemotherapy for BRCA-Mutated Prostate Cancer